Globus Medical, Inc.
GMED
$91.04
-$0.04-0.04%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -41.35% | 168.81% | 184.71% | -48.87% | 63.21% |
| Total Depreciation and Amortization | 0.75% | 6.86% | -3.06% | 1.62% | 5.24% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 141.56% | -632.72% | -70.46% | 77.32% | -34.15% |
| Change in Net Operating Assets | 103.07% | -689.81% | -64.79% | -21.78% | 129.80% |
| Cash from Operations | 220.68% | -56.08% | -15.71% | 3.28% | 275.34% |
| Capital Expenditure | 23.08% | -28.97% | -110.99% | 59.21% | -50.92% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | -- | -- | 100.00% | 97.95% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | 292.49% | -421.25% | 21.42% |
| Cash from Investing | 74.64% | -327.66% | 226.18% | -595.68% | -44.22% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | -- | -- | -- |
| Issuance of Common Stock | 135.87% | -58.15% | -83.80% | 194.76% | 65.09% |
| Repurchase of Common Stock | -54.89% | 86.69% | -20,536.40% | -11.19% | 59.67% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 15.05% | -2.16% | 54.85% | -179.56% | 10.56% |
| Cash from Financing | -28.49% | 96.08% | -1,163.73% | 205.02% | 124.86% |
| Foreign Exchange rate Adjustments | -96.43% | 305.76% | 182.73% | -205.06% | 7.92% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 161.39% | 28.27% | -299.89% | -23.86% | 276.75% |